Rephyll, a phytocannabinoid from Black Pepper exhibits analgesic effect through the endocannabinoid pathways, and has agonistic action on CB2 receptors.
Rephyll is a patent-pending innovation that incorporates terpenes from Black Pepper (derived from plants like Piper Nigrum) utilizing our proprietary powdered liposomal delivery platform Zeal Technology. Rephyll acts as a selective binder for the CB2 receptor, the therapeutic target for inflammation. It is also shown to have anti-microbial and anti-oxidant properties.
Rephyll is a patent-pending innovation that incorporates terpenes from Black Pepper (derived from plants like Piper Nigrum) utilizing our proprietary powdered liposomal delivery platform Zeal Technology. Rephyll acts as a selective binder for the CB2 receptor, the therapeutic target for inflammation. It is also shown to have anti-microbial and anti-oxidant properties.
Powered by Zeal Technology
Black pepper derivatives while rich in benefits has not reached its full market potential due to its limited functionality and stability in a finished product formulations. Rephyll®, leveraging Aurea Biolabs’ proprietary Zeal® Technology overcomes this by protecting the bio-active molecule against degradation and ensuring targeted delivery. Zeal technology has shown to increase bioavailability of a variety of bioactives.
Features
Formulated using cutting-edge Zeal Technology
Selective agonist of Cannabinoid Receptor Type 2 (CB2)
Significant cannabimimetic anti-inflammatory effects
Non GMO, Allergen Free and Gluten Free
Effective natural pain management
